Login / Signup

Reply to: Partially Levodopa-Responsive Parkinsonism in a Carrier of a Novel Pathogenic CLTC Variant.

Francesca NardecchiaSimone MartinelliLuca PolliniVincenzo Leuzzi
Published in: Movement disorders clinical practice (2024)
Keyphrases
  • parkinson disease
  • deep brain stimulation
  • cancer therapy
  • drug induced
  • drug delivery